No energy on Saxenda is a commonly reported concern among patients using this GLP-1 receptor agonist for weight management. Liraglutide 3.0 mg (Saxenda) works by reducing appetite and slowing gastric emptying, which can lead to significant caloric restriction and subsequent fatigue. Whilst some tiredness during initial treatment may be expected as the body adapts to lower energy intake, persistent or severe fatigue warrants medical review. Understanding the causes of low energy, implementing practical management strategies, and recognising when to seek professional advice can help patients navigate this side effect whilst continuing their weight management journey safely and effectively.

Why Saxenda May Cause Fatigue and Low Energy

Saxenda (liraglutide 3.0 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities. Fatigue and tiredness are reported side effects in the UK Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), and many patients experience low energy levels during treatment.

The mechanism behind this fatigue is multifactorial. Saxenda works by slowing gastric emptying and reducing appetite, which leads to a significant reduction in caloric intake. When patients consume substantially fewer calories than their body is accustomed to, this energy deficit can manifest as tiredness, lethargy, and reduced physical stamina. The body requires time to adapt to operating on lower energy reserves whilst mobilising fat stores for fuel.

Additionally, gastrointestinal side effects such as nausea, vomiting, and diarrhoea—which affect a considerable proportion of patients—can contribute to dehydration and electrolyte imbalances, further exacerbating feelings of fatigue. Saxenda may also cause small increases in heart rate, which some patients might experience alongside fatigue.

It is important to note that there is no official direct link established between liraglutide and chronic fatigue syndrome or persistent exhaustion. However, the indirect effects of rapid dietary change, potential nutrient deficiencies from reduced food intake, and the body's metabolic adaptation to weight loss can all contribute to the sensation of having 'no energy' during Saxenda treatment. Gallbladder disease, which can occur with rapid weight loss, may also cause malaise and fatigue in some patients.

Managing Tiredness While Taking Saxenda

Effective management of fatigue during Saxenda treatment requires a comprehensive approach addressing both medication tolerance and lifestyle factors. The gradual dose escalation protocol recommended by the manufacturer exists partly to minimise adverse effects, including energy-related concerns. Patients should follow the prescribed titration schedule, typically increasing by 0.6 mg weekly until reaching the maintenance dose of 3.0 mg daily. If side effects persist, the SmPC advises delaying dose escalation by an extra week or maintaining a lower dose until symptoms improve.

Maintaining adequate hydration is important, particularly given the gastrointestinal effects of Saxenda. The NHS recommends aiming for 6-8 glasses of fluid daily (approximately 1.5-2 litres), though this should be individualised based on activity levels, climate, and medical conditions. Those with cardiac or renal conditions should follow their healthcare provider's specific fluid intake guidance. Water, herbal teas, and sugar-free beverages are preferable choices.

Strategic meal timing and composition can help sustain energy levels throughout the day. Rather than attempting three large meals—which may be difficult given Saxenda's appetite-suppressing effects—smaller, more frequent meals or snacks may help maintain stable energy levels. Limiting alcohol and very high-fat meals, particularly around the time of Saxenda dosing, may help reduce nausea and improve tolerance.

Physical activity should be maintained but potentially modified during the adjustment period. Whilst exercise is crucial for weight management and overall health, patients experiencing significant fatigue may need to temporarily reduce intensity or duration. Gentle activities such as walking, swimming, or yoga can help maintain fitness without overwhelming an already fatigued system. As the body adapts to the medication and new eating patterns, energy levels often improve, allowing gradual return to previous activity levels.

Sleep hygiene deserves particular attention, as quality rest is essential for managing fatigue. Establishing consistent sleep-wake times, creating a restful bedroom environment, and avoiding screens before bedtime can all support better sleep quality during this adjustment period.

When to Seek Medical Advice About Fatigue on Saxenda

Whilst some degree of tiredness during the initial weeks of Saxenda treatment may be expected, certain presentations warrant prompt medical review. Patients should contact their GP or prescribing clinician if fatigue is severe, persistent, or progressively worsening despite adherence to management strategies.

Red flag symptoms requiring urgent medical attention include fatigue accompanied by:

• Chest pain, palpitations, or significant breathlessness at rest or with minimal exertion, which may indicate cardiovascular complications (call 999 or attend A&E for severe symptoms)

• Severe abdominal pain, especially if radiating to the back, with or without vomiting, which could suggest pancreatitis—a rare but serious adverse effect of GLP-1 receptor agonists. Stop taking Saxenda immediately and seek urgent medical care; do not restart if pancreatitis is confirmed

• Severe or persistent vomiting preventing adequate fluid or food intake, risking dehydration and electrolyte disturbances

• Signs of dehydration such as dark urine, dizziness on standing, confusion, or reduced urine output (attend A&E if severe)

• Symptoms suggestive of hypoglycaemia (particularly in patients with type 2 diabetes on concurrent glucose-lowering medications): tremor, sweating, confusion, or palpitations

• Jaundice, dark urine, or pale stools, which may indicate hepatobiliary complications

• Upper-right abdominal pain, especially after fatty meals, possibly with fever or jaundice, which could indicate gallbladder disease

If unsure about the severity of symptoms, contact NHS 111 for advice.

Routine medical review is advisable if fatigue significantly impairs daily functioning, work capacity, or quality of life. The prescriber may need to investigate alternative causes of tiredness, including anaemia, thyroid dysfunction, vitamin deficiencies (particularly B12, folate, or iron), or depression—conditions that may develop or be unmasked during significant dietary restriction.

Patients should also seek advice if they are unable to meet minimum nutritional requirements due to Saxenda's appetite-suppressing effects. NICE guidance on obesity management emphasises that pharmacological interventions should support, not replace, healthy eating patterns. If the medication prevents adequate nutrition, dose adjustment or treatment discontinuation may be necessary.

As per NICE guidance (TA664) and the SmPC, treatment should be reviewed after 12 weeks on the 3.0 mg dose, and discontinued if weight loss of at least 5% of initial body weight has not been achieved. Patients should report any suspected side effects via the MHRA Yellow Card Scheme.

Nutritional Strategies to Maintain Energy During Saxenda Treatment

Optimising nutritional intake is crucial for maintaining energy levels whilst taking Saxenda, particularly given the medication's appetite-suppressing effects. The challenge lies in consuming adequate nutrients within a reduced caloric intake, making food quality paramount.

Protein intake helps preserve lean muscle mass during weight loss and provides sustained energy. Higher protein intake (around 1.0–1.2 grams per kilogram of ideal body weight daily) may be beneficial for many people, though requirements should be individualised—particularly for those with kidney disease who may need lower amounts. Good sources include lean meats, fish, eggs, dairy products, legumes, and plant-based alternatives. Protein also promotes satiety and has a higher thermic effect than carbohydrates or fats, supporting weight management goals.

Complex carbohydrates offer sustained energy release without the peaks and troughs associated with refined sugars. Wholegrain bread, brown rice, quinoa, oats, and starchy vegetables provide not only energy but also essential B vitamins crucial for energy metabolism. While some people may benefit from moderating carbohydrate intake, very low-carbohydrate diets should be discussed with healthcare professionals, as individual responses vary and additional fatigue may occur in some people.

Micronutrient adequacy requires particular attention during caloric restriction. Key nutrients for energy metabolism include:

• Iron: Found in red meat, dark leafy greens, and fortified cereals; deficiency causes anaemia and profound fatigue

• B vitamins (particularly B12, folate, and B6): Essential for energy production; sources include meat, fish, eggs, dairy, and fortified plant-based alternatives

• Magnesium: Supports hundreds of enzymatic reactions including energy production; present in nuts, seeds, wholegrains, and green vegetables

• Vitamin D: The NHS recommends 10 micrograms (400 IU) daily during autumn and winter months for all adults, with year-round supplementation for those with limited sun exposure or in higher-risk groups

Healthy fats should not be neglected despite their caloric density. Omega-3 fatty acids from oily fish, nuts, seeds, and avocados support cellular function and may help reduce inflammation. Including small portions of these foods ensures adequate fat-soluble vitamin absorption.

Patients may benefit from consultation with a registered dietitian who can provide personalised nutritional planning, ensuring adequate intake of all essential nutrients within the constraints of reduced appetite. Some individuals may require targeted supplementation, particularly if dietary intake is severely restricted or if pre-existing deficiencies are identified through blood testing. If supplements are used, patients should not exceed recommended daily amounts unless directed by a healthcare professional, and should check for potential interactions with medications. In line with NICE guidance and British Dietetic Association recommendations, a food-first approach is generally preferable where feasible.

Frequently Asked Questions